Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles
- PMID: 2393869
Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles
Abstract
In breast cancer cell lines, pro-cathepsin D is synthesized in excess and abnormally processed, resulting in its slower maturation and increased secretion into the culture medium. Since this lysosomal protease is only active at acidic pH, we have searched for acidic compartments other than lysosomes where cathepsin D might be active when MCF7 cells are plated on corneal extracellular matrix. We found large acidic intracellular vesicles (1.5 to 20 microns in diameter) by acridine orange and 3-(2,4-dinitroanilino)-3'-amino-N-methyldipropylamine staining, two fluorescent probes which reveal acidic compartments. These vesicles were actively acidified. They were 2- to 20-fold more abundant in MCF7 breast cancer cells and primary cultures of human breast cancers cells than in primary cultures of normal mammary epithelial cells. In living MCF7 cells, high resolution video-enhanced microscopy showed that these vesicles were mobile and intracellular. Double immunolocalization indicated that they contained mature cathepsin D (but no detectable pro-cathepsin D) and endocytosed extracellular material. This material (dextran, transferrin, and extracellular matrix) and the association with other lysosomal enzymes varied according to the vesicles, suggesting their heterogeneity (large endosomes or phagosomes). We conclude that, in breast cancer cells, cathepsin D may digest intracellularly phagocytosed and/or endocytosed extracellular matrix in large acidic vesicles. We propose that the higher expression of cathepsin D associated with the increased number of large acidic vesicles in breast cancer cells may facilitate digestion of basement membrane and consequently metastasis.
Similar articles
-
In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.Cancer Res. 1988 Jul 1;48(13):3688-92. Cancer Res. 1988. PMID: 3378211
-
Biological and clinical significance of cathepsin D in breast cancer.Semin Cancer Biol. 1990 Apr;1(2):153-60. Semin Cancer Biol. 1990. PMID: 2103491 Review.
-
[Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].C R Seances Soc Biol Fil. 1998;192(2):241-51. C R Seances Soc Biol Fil. 1998. PMID: 9841098 Review. French.
-
Biological and clinical significance of cathepsin D in breast cancer metastasis.Stem Cells. 1996 Nov;14(6):642-50. doi: 10.1002/stem.140642. Stem Cells. 1996. PMID: 8948022 Review.
-
[The presence of large acidic vesicles is correlated with in vitro invasive potential of breast cancer cells].C R Acad Sci III. 1993;316(4):421-4. C R Acad Sci III. 1993. PMID: 8402270 French.
Cited by
-
Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines.Br J Cancer. 1997;75(7):951-9. doi: 10.1038/bjc.1997.166. Br J Cancer. 1997. PMID: 9083329 Free PMC article.
-
Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers.Mol Divers. 2016 May;20(2):521-35. doi: 10.1007/s11030-015-9645-8. Epub 2015 Nov 13. Mol Divers. 2016. PMID: 26563150
-
Imaging proteolysis by living human breast cancer cells.Neoplasia. 2000 Nov-Dec;2(6):496-504. doi: 10.1038/sj.neo.7900116. Neoplasia. 2000. PMID: 11228542 Free PMC article.
-
MCT4 and CD147 colocalize with MMP14 in invadopodia and support matrix degradation and invasion by breast cancer cells.J Cell Sci. 2024 Apr 15;137(8):jcs261608. doi: 10.1242/jcs.261608. Epub 2024 Apr 30. J Cell Sci. 2024. PMID: 38661040 Free PMC article.
-
Extracellular acidification alters lysosomal trafficking in human breast cancer cells.Neoplasia. 2003 Nov-Dec;5(6):533-45. doi: 10.1016/s1476-5586(03)80037-4. Neoplasia. 2003. PMID: 14965446 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical